CN104707004A - 降血压的药物 - Google Patents
降血压的药物 Download PDFInfo
- Publication number
- CN104707004A CN104707004A CN201510090865.6A CN201510090865A CN104707004A CN 104707004 A CN104707004 A CN 104707004A CN 201510090865 A CN201510090865 A CN 201510090865A CN 104707004 A CN104707004 A CN 104707004A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- medicine
- fructus
- blood pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 230000036772 blood pressure Effects 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title description 4
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 14
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 10
- 241000345998 Calamus manan Species 0.000 claims description 9
- 241000519950 Chara fragilis Species 0.000 claims description 9
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 9
- 235000012950 rattan cane Nutrition 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 244000268590 Euryale ferox Species 0.000 claims description 8
- 235000006487 Euryale ferox Nutrition 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 101100336279 Caenorhabditis elegans icl-1 gene Proteins 0.000 claims description 4
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 240000001980 Cucurbita pepo Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 206010020772 Hypertension Diseases 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000174681 Michelia champaca Species 0.000 abstract 2
- 244000161286 Allium victorialis Species 0.000 abstract 1
- 235000011644 Allium victorialis Nutrition 0.000 abstract 1
- 241000772998 Arthraxon Species 0.000 abstract 1
- 241000209439 Cabomba caroliniana Species 0.000 abstract 1
- 241000707052 Centaurium pulchellum Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 235000014493 Crataegus Nutrition 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 abstract 1
- 244000249585 Elaeagnus conferta Species 0.000 abstract 1
- 235000009709 Geum japonicum Nutrition 0.000 abstract 1
- 241001618015 Geum japonicum Species 0.000 abstract 1
- 241000594394 Hedyotis Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 240000005178 Oxalis martiana Species 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 241000446670 Tylophora mollissima Species 0.000 abstract 1
- 230000000361 pesticidal effect Effects 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 230000006870 function Effects 0.000 description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 8
- 241000219122 Cucurbita Species 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010053615 Thermal burn Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000002215 flavonoids Chemical group 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- -1 dioxygen flavonoid glycoside Chemical class 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000004141 microcephaly Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 150000003648 triterpenes Chemical group 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药,特别一种降血压的药物。由以下重量份数的原料制成:紫贝齿6-12份、茖葱4-5份、石斛4-8份、桂圆肉5-10份、蒲公英8份、一支箭7份、芦根5-9份、沙糖根4-8份、鱼草7-9份、荩草7-10份、柔毛水杨梅6-9份、埃蕾6-10份、桔梗芦头4-9份、桄榔子5-10份、红花醡浆草7-10份、通脉丹9-15份、山楂干8份、石菖蒲8份、五指毛桃8份、盐匏藤果10份、栝楼茎叶7份、黄缅桂果7份、牡丹皮15份、益母草8份。上述诸药配伍,治疗高血压的效果明显,避免了现有高血压人群对高血压药物的依赖,药效快、疗效好、无毒副作用,其有效率高达100%。
Description
(一) 技术领域
本发明涉及药品,特别一种降血压的药物。
(二) 背景技术
正常人的血压随内外环境变化在一定范围内波动。在整体人群,血压水平随年龄逐渐升高,以收缩压更为明显,但50岁后舒张压呈现下降趋势,脉压也随之加大。近年来,人们对心血管病多重危险因素作用以及心、脑、肾靶器官保护的认识不断深入,高血压的诊断标准也在不断调整,目前认为同一血压水平的患者发生心血管病的危险不同,因此有了血压分层的概念,即发生心血管病危险度不同的患者,适宜血压水平应有不同。医生面对患者时在参考标准的基础上,根据其具体情况判断该患者最合适的血压范围,采用针对性的治疗措施。长期服用西药毒副作用不容忽视。中医力求病因,有时可能取得意想不到的效果,但目前能同时治疗高血压的药物非常少见,效果仍需要提升。
(三) 发明内容
本发明为了弥补现有技术的不足,提供了一种效果好、效果持久的降血压的药物。
本发明是通过如下技术方案实现的:
一种降血压的药物,其特殊之处在于:由以下重量份数的原料制成:
紫贝齿6-12份、茖葱4-5份、石斛4-8份、旋覆花7份、荔枝核5-8份、芡实7-9份、小伸筋草6-9份、桂圆肉5-10份、蒲公英8份、一支箭7份、芦根5-9份、沙糖根4-8份、鱼草7-9份、荩草7-10份、柔毛水杨梅6-9份、埃蕾6-10份、桔梗芦头4-9份、桄榔子5-10份、红花醡浆草7-10份、通脉丹9-15份、山楂干8份、石菖蒲8份、五指毛桃8份、盐匏藤果10份、栝楼茎叶7份、黄缅桂果7份、牡丹皮15份、益母草8份。
本发明的降血压的药物,更优方案在于:由以下重量份数的原料制成:
紫贝齿10份、茖葱4份、石斛8份、旋覆花7份、荔枝核6份、芡实7份、小伸筋草9份、桂圆肉6份、蒲公英8份、一支箭7份、芦根8份、沙糖根6份、鱼草7份、荩草10份、柔毛水杨梅7份、埃蕾9份、桔梗芦头4份、桄榔子10份、红花醡浆草9份、通脉丹9份、山楂干8份、石菖蒲8份、五指毛桃8份、盐匏藤果10份、栝楼茎叶7份、黄缅桂果7份、牡丹皮15份、益母草8份。
使用方法:水煎服,每日一剂,分两次温服。
下面为本发明中各药材的功能及作用:
紫贝齿:无臭,无味。以壳厚、有光泽者为佳。性味和功用:咸,平。归肝经。清心安神,平肝明目。用于惊悸,心烦不眠,目赤眩晕,斑疹。
石斛:甘,微寒,归胃,肾经。功效: 养阴清热,益胃生津。主治:(1)用于肝肾阴虚,腰膝酸软,虚热不退,以及目暗不明,视物不清等证。(2)热病津伤,烦热口渴,舌绛苔黑等症及胃阴不足,舌红口干,食少干呕等。
旋覆花:苦、辛、咸,微温,归肺、脾、大肠经。功效: 降气止呕,化痰止咳。主治:(1)本品性善下降,能入脾胃,善于降胃气而止呕意,主要用于脾胃虚寒或痰湿内聚,胃失和降所致的噫气呕吐,常与代赭石、半夏、生姜等品配伍。(2)旋覆花能入肺经,可化痰饮、下肺气,适用于痰壅气逆及痰饮蓄结所致的喘咳痰多之症,可与桑白皮、甜葶苈、陈皮、半夏等品配伍;如有表证者,当配荆芥、细辛、前胡、半夏等同用。
荔枝核:辛,温,归肝经。功效:疏肝理气,散结止痛。主治:(1)本品药性辛温,专入肝经,功能疏肝理气、散结止痛,为治疗肝经寒凝气滞所致的疝气,睪丸肿痛的常用要药,常与小茴香、吴茱萸、橘核等药配合应用。(2)本品疏肝理气止痛,用于肝气郁滞的胃脘疼痛,可与木香同用;(3)若用肝郁气滞的痛经及产后腹痛,可配香附同用。 芡实:性味:味甘、涩,性平。归经:归脾、肾经。功效:益肾固精,补脾止泻,除湿止带。主治:用于遗精滑精,遗尿尿频,脾虚久泻,白浊,带下。
小伸筋草:性味归经:云南中草药》:“苦涩,温。”入肾,胃二经。功用主治-小伸筋草的功效:①《云南中草药》;疏经活络,温肾止痛。治风湿,周身酸冷,胃寒痛。
桂圆肉因其种圆黑光泽,种脐突起呈白色,看似传说中“龙”的眼睛,所以得名。新鲜的龙眼肉质极嫩,汁多甜蜜,美味可口,实为其他果品所不及。鲜龙眼烘成干果后即成为中药里的桂圆。生药龙眼肉为由顶端纵向裂开有不规则块片,长约1.5厘米,宽1.3~3.5厘米,厚不及1毫米。表面黄棕色,半透明;靠近果皮的一面皱缩不平,粗糙,靠近种皮的一面,光亮而有纵皱纹。质柔软而微有粘性,常粘结呈块状。气香,味浓甜而特殊。补益心脾,养血安神。用于气血不足、心悸怔忡、健忘失眠、血虚萎黄。
芦根:性味:甘,寒。归经:归肺、胃经。功效:清热泻火,生津止渴,除烦,止呕,利尿。主治:用于热病烦渴,肺热燥咳,内热消渴,疮疡肿毒。
沙糖根,为茜草科植物小头凉喉茶的全株。生于山野疏林灌木丛中。可入药。具有散寒通络,养血,截疟的功效。
鱼草: 归经:肺经.功效:祛痰;止咳;平喘。主治:咳嗽;痰多;胸闷。功效分类:宣肺药;祛痰药。
茖葱:性味:《千金·食治》:"辛,微温,无毒。"归经:肺经。功能主治:散瘀;止血;解毒。主跌打损伤;血瘀肿痛;衄血;疮痈肿痛。
荩草:性味:①《本经》:"味苦,平。"②《别录》:"无毒。"功用主治:止咳、定喘,杀虫。
柔毛水杨梅:苦、辛;性寒。归经:脾;肾;肝经.功效:补肾平肝,活血消肿.功效分类:补益药.主治:头晕目眩;小儿惊风;阳痿;遗精;虚劳咳嗽;风湿痹痛;月经不调;疮疡肿痛;跌打损伤.
埃蕾:性味:苦,寒。功能:清热解毒。主治:肝炎,胆囊炎,头痛,发热,牙痛,扁桃体炎。
桔梗芦头:功用主治:吐上膈风热痰实,生研末,白汤调服一钱,探吐。
桄榔子:性味①《开宝本草》:" 味苦,乎,无毒。"②《本草汇言》:" 味苦,气温,无毒。"功用主治:①《开宝本草》:"主宿血。"②《本草汇言》:"破宿食、积血。磨汁治妇人产后儿枕血瘕诸疼,及心胃寒疼。"
红花醡浆草:性味归经:酸,寒。功能主治:清热解毒,散瘀消肿,调经。用于肾盂肾炎,痢疾,咽炎,牙痛,月经不调,白带;外用治毒蛇咬伤,跌打损伤,烧烫伤。
通脉丹:来源:为双子叶植物药萝藦科植物通脉丹的全株和根。功效:燥湿化痰。主治:治咳嗽、气逆、胸满。性味归经:辛,温。肺经。
石菖蒲:功能主治:化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。理气,活血,散风,去湿。治癫痫,痰厥,热病神昏,健忘,气闭耳聋,心胸烦闷,胃痛,腹痛,风寒湿痹,痈疽肿毒,跌打损伤。
山楂干能防治心血管疾病,具有扩张血管、强心、增加冠脉血流量、改善心脏活力、兴奋中枢神经系统、降低血压和胆固醇、软化血管及利尿和镇静作用; 防治动脉硬化,防衰老、抗癌的作用,山楂干含绿原酸(chlorogenic acid)、咖啡酸、山楂酸( crataegolic acid)、齐菊果酸、槲皮素、熊果酸、齐墩果酸、金丝桃甙(hyperin)、表儿茶精(epicatechin)等。为蔷薇科植物山楂、山里红或野山楂的果实。主产于山东、河南、江苏、浙江等地。山楂干的主要成分是黄酮类物质, 对心血管系统有明显的药理作用。 从山楂中分离的黄酮成分有30 余种, 主要有含碳键的黄酮苷类、黄酮醇及其苷类、双氧黄酮苷类、聚合黄酮类。另一类较为重要的成分是三萜类物质,有强心、增加冠脉血流、改善血流循环等重要作用。此外, 山楂中含有机酸如氯原酸、咖啡酸及鞣质、鞣酐、表儿茶酚、胆碱、乙酰胆碱、β 谷甾醇、胡萝卜素及大量Vit C 等。性味归经:味酸、甘,性微温。归脾、胃、肝经。功用主治:开胃消食、化滞消积、活血散瘀、化痰行气。用于肉食滞积、症瘕积聚、腹胀痞满、瘀阻腹痛、痰饮、泄泻、肠风下血等。
五指毛桃:煎剂、乙醇提取物、乙醇回流后残渣的水提取物,分别给小鼠灌服对氨水喷雾引起的咳嗽均有明显的止咳作用。试管试验对金黄色葡萄球菌、甲型链球菌亦有较好的抑菌作用。功效:健脾补肺;行气利湿;舒筋活络。主治:五指毛桃具有健脾补肺、行气利湿、舒筋活络之功,岭南地区的中医或少数民族民间医生常用于治疗脾虚浮肿、食少无力、肺痨咳嗽、盗汗、带下、产后无乳、月经不调、风湿痹痛、水肿等症。
盐匏藤果:性味:酸;平。功能主治:涩肠止痢。主肠炎;痢疾。
栝楼茎叶:来源:为葫芦科植物栝楼的茎叶,植物形态详"栝楼"条。性味:《纲目》:"酸,寒,无毒。"功用主治:《别录》:"疗中热伤暑。"《本草正义》:"瓜蒌茎叶治中热伤暑,以其清芬凉爽,故善涤暑。又其味微酸,自能振刷精力,以御酷暑之炎热。亦犹孙真人所谓季夏之间,困乏无力,宜服五味子汤以收耗散之气,使人精神顿加也。"
黄缅桂果:采集:夏、秋采收,去皮,晒干。功用主治:健胃止痛。治消化不良,胃痛。
益母草 :辛微苦寒。调经,活血,祛瘀生新,止痛,利尿,降血压,扩张血管,抗肾上腺素作用,改善微循环,抗凝,抗血小板凝集,溶栓,调整肠管平滑肌活动,兴奋呼吸中枢。
蒲公英:性味功能:甘,微苦,寒。清热解毒,消痈散结。归经:入脾、胃、肾三经。主治:上呼吸道感染,眼结膜炎,流行性腮腺炎,高血糖,乳痈肿痛,胃炎,痢疾,肝炎,胆囊炎,急性阑尾炎,泌尿系感染,盆腔炎,痈疖疔疮,咽炎,治急性乳腺炎,淋巴腺炎,瘰疠,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎、尿路感染。
一支箭:药性;苦,甘,微寒,归肝经,用法与用量:消热解毒,活血祛瘀,主治疼肿,毒蛇咬伤,烫伤,跌打等。
本发明的有益效果是:上述诸药配伍,具有肝潜阳、活血化瘀、清利肝胆湿热、增加食欲、加强血液循、滋补肝肾、疏肝理气的功效。使用方便,没有副作用,治疗高血压的效果明显,避免了现有高血压人群对高血压药物的依赖,药效快、疗效好、无毒副作用,其有效率高达100%。
(四) 具体实施方式
实施例1
将紫贝齿6g、茖葱4 g、石斛4g、旋覆花7 g、荔枝核8 g、芡实9 g、小伸筋草9 g、桂圆肉10 g、蒲公英8 g、一支箭7 g、芦根6g、沙糖根6g、鱼草8 g、荩草8 g、柔毛水杨梅7 g、埃蕾8 g、桔梗芦头7g、桄榔子7 g、红花醡浆草8 g、通脉丹9 g、山楂干8 g、石菖蒲8 g、五指毛桃8 g、盐匏藤果10 g、栝楼茎叶7 g、黄缅桂果7 g、牡丹皮15 g、益母草8 g,用水煎制成汤剂。
用法用量:水煎服,每日一剂,分两次温服。
实施例2
将紫贝齿12g、茖葱5 g、石斛8 g、旋覆花7 g、荔枝核5 g、芡实7g、小伸筋草6g、桂圆肉5 g、蒲公英8 g、一支箭7 g、芦根5 g、沙糖根4 g、鱼草7g、荩草7 g、柔毛水杨梅6 g、埃蕾6 g、桔梗芦头4g、桄榔子5g、红花醡浆草7g、通脉丹15g、山楂干8 g、石菖蒲8 g、五指毛桃8 g、盐匏藤果10 g、栝楼茎叶7 g、黄缅桂果7 g、牡丹皮15 g、益母草8 g,用水煎制成汤剂。
用法用量:水煎服,每日一剂,分两次温服。
实施例3
将紫贝齿9g、茖葱4 g、石斛6 g、旋覆花7 g、荔枝核6 g、芡实8g、小伸筋草7 g、桂圆肉8 g、蒲公英8 g、一支箭7 g、芦根9 g、沙糖根8 g、鱼草9 g、荩草10 g、柔毛水杨梅9 g、埃蕾10 g、桔梗芦头9 g、桄榔子10 g、红花醡浆草10 g、通脉丹12g、山楂干8 g、石菖蒲8 g、五指毛桃8 g、盐匏藤果10 g、栝楼茎叶7 g、黄缅桂果7 g、牡丹皮15 g、益母草8 g,用水煎制成汤剂。
用法用量:水煎服,每日一剂,分两次温服。
实施例4
将紫贝齿10g、茖葱4 g、石斛8 g、旋覆花7 g、荔枝核6g、芡实7 g、小伸筋草9 g、桂圆肉6 g、蒲公英8 g、一支箭7 g、芦根8 g、沙糖根6 g、鱼草7 g、荩草10 g、柔毛水杨梅7 g、埃蕾9 g、桔梗芦头4 g、桄榔子10 g、红花醡浆草9 g、通脉丹9 g、山楂干8 g、石菖蒲8 g、五指毛桃8 g、盐匏藤果10 g、栝楼茎叶7 g、黄缅桂果7 g、牡丹皮15 g、益母草8 g,用水煎制成汤剂。
用法用量:水煎服,每日一剂,分两次温服。
实施例5临床观察
(1)一般资料
本发明人于2009年至今对500例门诊患者进行临床观察治疗,年龄45到75岁不等,总有效率为100%,治愈率高达93.1%。
(2)治疗方法:水煎服,每日一剂,分两次温服,3-5天为一疗程。
(3)疗效评定标准
治愈:症状体征完全消失;
有效:症状体征较前减轻;
无效:症状体征与治疗前无改善。
(5)典型病例:
刘某,女,62岁,菏泽曹县人。2010 年8月精神萎靡、注意力不集中、记忆力下降,经诊断为高血压,2010年8月开始服用本发明药物,服用2天后注意力集中,精神变好,继续服用3个疗程后,停药,至今未复发。
张某某,男,46岁,山东聊城人,2011年出现头痛、头晕等症状,经诊断患有高血压,2012年开始服用本发明中药,1个疗程后症状减轻大大减轻,精神恢复,继续服用3个疗程后停药。
韩某,男,70岁,济南人, 2012年开始出现头晕、无力、胸闷、视线模糊等状况,有时还伴有头痛、恶心症状,经诊断患有高血压,随服用本发明中药,1个疗程后症状减轻,继续服用4个疗程后停药,至今未复发。
Claims (2)
1.一种降血压的药物,其特征在于:由以下重量份数的原料制成:
紫贝齿6-12份、茖葱4-5份、石斛4-8份、旋覆花7份、荔枝核5-8份、芡实7-9份、小伸筋草6-9份、桂圆肉5-10份、蒲公英8份、一支箭7份、芦根5-9份、沙糖根4-8份、鱼草7-9份、荩草7-10份、柔毛水杨梅6-9份、埃蕾6-10份、桔梗芦头4-9份、桄榔子5-10份、红花醡浆草7-10份、通脉丹9-15份、山楂干8份、石菖蒲8份、五指毛桃8份、盐匏藤果10份、栝楼茎叶7份、黄缅桂果7份、牡丹皮15份、益母草8份。
2.根据权利要求1所述的降血压的药物,其特征在于:由以下重量份数的原料制成:
紫贝齿10份、茖葱4份、石斛8份、旋覆花7份、荔枝核6份、芡实7份、小伸筋草9份、桂圆肉6份、蒲公英8份、一支箭7份、芦根8份、沙糖根6份、鱼草7份、荩草10份、柔毛水杨梅7份、埃蕾9份、桔梗芦头4份、桄榔子10份、红花醡浆草9份、通脉丹9份、山楂干8份、石菖蒲8份、五指毛桃8份、盐匏藤果10份、栝楼茎叶7份、黄缅桂果7份、牡丹皮15份、益母草8份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510090865.6A CN104707004A (zh) | 2015-02-28 | 2015-02-28 | 降血压的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510090865.6A CN104707004A (zh) | 2015-02-28 | 2015-02-28 | 降血压的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104707004A true CN104707004A (zh) | 2015-06-17 |
Family
ID=53407048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510090865.6A Pending CN104707004A (zh) | 2015-02-28 | 2015-02-28 | 降血压的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104707004A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012410A (zh) * | 2015-08-08 | 2015-11-04 | 王恒信 | 由胖血藤制成的治疗高血压的护理辅助用药物胶囊及制法 |
| CN109730223A (zh) * | 2019-03-05 | 2019-05-10 | 延边大学 | 一种寒葱饮料及其制备方法与应用 |
| TWI680724B (zh) * | 2018-10-09 | 2020-01-01 | 兟齊綜合事業有限公司 | 血壓與血糖調降組合物與一葉草萃取物於製備血壓與血糖調降組合物之用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101595927A (zh) * | 2008-06-06 | 2009-12-09 | 刘泳宏 | 一种天然养脏降脂、降糖、降压茶及制作方法 |
| CN101947303A (zh) * | 2010-10-11 | 2011-01-19 | 许文成 | 一种根治高血压的药物及其制备方法 |
| CN101972373A (zh) * | 2010-11-06 | 2011-02-16 | 赵全会 | 治疗高血压、高血糖、高血脂的中药制剂 |
-
2015
- 2015-02-28 CN CN201510090865.6A patent/CN104707004A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101595927A (zh) * | 2008-06-06 | 2009-12-09 | 刘泳宏 | 一种天然养脏降脂、降糖、降压茶及制作方法 |
| CN101947303A (zh) * | 2010-10-11 | 2011-01-19 | 许文成 | 一种根治高血压的药物及其制备方法 |
| CN101972373A (zh) * | 2010-11-06 | 2011-02-16 | 赵全会 | 治疗高血压、高血糖、高血脂的中药制剂 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012410A (zh) * | 2015-08-08 | 2015-11-04 | 王恒信 | 由胖血藤制成的治疗高血压的护理辅助用药物胶囊及制法 |
| TWI680724B (zh) * | 2018-10-09 | 2020-01-01 | 兟齊綜合事業有限公司 | 血壓與血糖調降組合物與一葉草萃取物於製備血壓與血糖調降組合物之用途 |
| CN109730223A (zh) * | 2019-03-05 | 2019-05-10 | 延边大学 | 一种寒葱饮料及其制备方法与应用 |
| CN109730223B (zh) * | 2019-03-05 | 2022-03-01 | 延边大学 | 一种寒葱饮料及其制备方法与应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102784363B (zh) | 一种治疗胰腺癌的中药组合物及其制备方法 | |
| CN103432393B (zh) | 一种治疗高血压的中药组合物 | |
| CN104873947A (zh) | 用于治疗狗急性上消化道出血的药物组合物及其制备方法 | |
| CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN104083740A (zh) | 一种用于增肥的内服中药 | |
| CN103736072B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
| CN103432390B (zh) | 一种治疗冠心病的药物及其制备方法 | |
| CN107308097A (zh) | 一种化妆组成物 | |
| CN104069390A (zh) | 一种用于增肥的中药汤剂 | |
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN101979009A (zh) | 一种治疗脾虚的中药 | |
| CN104522213A (zh) | 适宜三高人群饮用的茶饮及其制备方法 | |
| CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
| CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
| CN105106515A (zh) | 一种用于治疗心绞痛的中药制剂及制备方法 | |
| CN104666999A (zh) | 一种降血压的中药配方 | |
| CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
| CN102579799A (zh) | 一种治疗产后血虚发热型的中药组合物 | |
| CN104666998A (zh) | 一种用于治疗高血压的中药组合物 | |
| CN105687738A (zh) | 一种用于治疗顽固性咳嗽的中药冲剂及制备方法 | |
| CN105381220A (zh) | 一种明目降脂的菟丝子保健茶 | |
| CN105106916A (zh) | 一种产后护理用中药 | |
| CN104173973A (zh) | 一种治疗痢疾的口服液及其制备方法 | |
| CN104117020A (zh) | 一种治疗心房颤动的中药配方 | |
| CN104667001A (zh) | 一种用于治疗胃癌的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150617 |